Ionis Pharmaceuticals, Inc.
IONSNASDAQHealthcare● Active
$73.54
$-0.94(-1.26%)
Market Cap$12.2B
P/E Ratio—
52W High$86.74
52W Low$34.78
Ionis Pharmaceuticals, Inc.（IONS）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IONS · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $2.68B | $2.30B | $2.33B | $2.00B | $2.13B |
| Net Receivables | $0.07B | $0.09B | $0.10B | $0.03B | $0.06B |
| Inventory | $0.01B | $0.01B | $0.01B | $0.02B | $0.02B |
| Total Current Assets | $2.99B | $2.62B | $2.64B | $2.20B | $2.35B |
| PP&E Net | $0.36B | $0.26B | $0.24B | $0.26B | $0.20B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.03B |
| Total Assets | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B |
| Liabilities | |||||
| Short-Term Debt | $0.45B | $0.01B | $0.05B | $0.01B | $0.00B |
| Accounts Payable | $0.03B | $0.04B | $0.03B | $0.02B | $0.01B |
| Total Current Liabilities | $0.78B | $0.31B | $0.45B | $0.31B | $0.24B |
| Long-Term Debt | $1.90B | $1.25B | $1.23B | $1.18B | $1.23B |
| Total Liabilities | $3.03B | $2.42B | $2.60B | $1.96B | $1.84B |
| Stockholders Equity | |||||
| Retained Earnings | ($2.63B) | ($2.25B) | ($1.80B) | ($1.43B) | ($1.16B) |
| Total Stockholders Equity | $0.49B | $0.59B | $0.39B | $0.57B | $0.77B |
| Total Liab & Equity(computed) | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B |
| Debt Summary | |||||
| Total Debt | $2.61B | $1.42B | $1.45B | $1.37B | $1.25B |
| Net Debt | $2.24B | $1.17B | $1.05B | $1.09B | $0.38B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Ionis Pharmaceuticals, Inc.
关于Ionis Pharmaceuticals, Inc.（IONS）资产负债表
Ionis Pharmaceuticals, Inc.总资产$3.52B，现金及短期投资$2.68B，总负债$3.03B，总债务$2.61B，股东权益$0.49B。
常见问题
IONS · 4 问Ionis Pharmaceuticals, Inc.总债务$2.61B，净债务$2.24B。
IONS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10